G

Gushengtang Holdings Ltd
HKEX:2273

Watchlist Manager
Gushengtang Holdings Ltd
HKEX:2273
Watchlist
Price: 33.85 HKD -4.24% Market Closed
Market Cap: 8.1B HKD
Have any thoughts about
Gushengtang Holdings Ltd?
Write Note

Gushengtang Holdings Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gushengtang Holdings Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
G
Gushengtang Holdings Ltd
HKEX:2273
Total Receivables
ÂĄ181.6m
CAGR 3-Years
22%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Total Receivables
ÂĄ5.7B
CAGR 3-Years
7%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Total Receivables
ÂĄ238.6m
CAGR 3-Years
9%
CAGR 5-Years
16%
CAGR 10-Years
32%
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Total Receivables
ÂĄ1.6B
CAGR 3-Years
8%
CAGR 5-Years
-1%
CAGR 10-Years
35%
Dian Diagnostics Group Co Ltd
SZSE:300244
Total Receivables
ÂĄ9B
CAGR 3-Years
12%
CAGR 5-Years
19%
CAGR 10-Years
37%
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Total Receivables
ÂĄ3.4B
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
50%
No Stocks Found

Gushengtang Holdings Ltd
Glance View

Market Cap
8.3B HKD
Industry
Health Care

Gushengtang Holdings Ltd. operates the neo-TCM primary care platform, which combines inviting in-person care and seamless digital health powered by internet and AI technologies. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2021-12-10. The firm operates in two segments. Medical and Health Solutions segment is engaged in providing customers with traditional Chinese medical and health services through offline medical institutions and online medical and health platforms, including consultation, diagnosis, prescription services, decoctions and physical therapy. Sales of Medical and Health Products segment is mainly responsible for the sales of related products. The firm's main products include Ejiao, Cordyceps, cubilose, dendrobium, American Ginseng and other medicinal materials. The firm also provides honey, Ejiao cake and other nutritional products.

Intrinsic Value
74.36 HKD
Undervaluation 54%
Intrinsic Value
Price
G

See Also

What is Gushengtang Holdings Ltd's Total Receivables?
Total Receivables
181.6m CNY

Based on the financial report for Dec 31, 2023, Gushengtang Holdings Ltd's Total Receivables amounts to 181.6m CNY.

What is Gushengtang Holdings Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
18%

Over the last year, the Total Receivables growth was 103%. The average annual Total Receivables growth rates for Gushengtang Holdings Ltd have been 22% over the past three years , 18% over the past five years .

Back to Top